Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:COVH - FR0000060303 - REIT

23.6 EUR
0 (0%)
Last: 1/14/2026, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, COVH scores 4 out of 10 in our fundamental rating. COVH was compared to 42 industry peers in the Diversified REITs industry. Both the profitability and the financial health of COVH get a neutral evaluation. Nothing too spectacular is happening here. COVH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • COVH had positive earnings in the past year.
  • In the past year COVH had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: COVH reported negative net income in multiple years.
  • In the past 5 years COVH always reported a positive cash flow from operatings.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • COVH has a Return On Assets of 2.88%. This is comparable to the rest of the industry: COVH outperforms 59.52% of its industry peers.
  • COVH's Return On Equity of 5.87% is fine compared to the rest of the industry. COVH outperforms 61.90% of its industry peers.
  • COVH has a Return On Invested Capital (3.67%) which is in line with its industry peers.
  • COVH had an Average Return On Invested Capital over the past 3 years of 3.85%. This is in line with the industry average of 3.45%.
Industry RankSector Rank
ROA 2.88%
ROE 5.87%
ROIC 3.67%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • COVH's Profit Margin of 78.86% is amongst the best of the industry. COVH outperforms 88.10% of its industry peers.
  • In the last couple of years the Profit Margin of COVH has declined.
  • COVH has a Operating Margin of 101.41%. This is amongst the best in the industry. COVH outperforms 97.62% of its industry peers.
  • In the last couple of years the Operating Margin of COVH has remained more or less at the same level.
Industry RankSector Rank
OM 101.41%
PM (TTM) 78.86%
GM N/A
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COVH is destroying value.
  • The number of shares outstanding for COVH remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, COVH has more shares outstanding
  • COVH has a worse debt/assets ratio than last year.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.04, we must say that COVH is in the distress zone and has some risk of bankruptcy.
  • COVH's Altman-Z score of 1.04 is fine compared to the rest of the industry. COVH outperforms 66.67% of its industry peers.
  • COVH has a debt to FCF ratio of 12.71. This is a negative value and a sign of low solvency as COVH would need 12.71 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 12.71, COVH perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
  • A Debt/Equity ratio of 0.70 indicates that COVH is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.70, COVH perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Altman-Z 1.04
ROIC/WACC0.68
WACC5.38%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • COVH has a Current Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
  • COVH has a Current ratio of 1.16. This is amongst the best in the industry. COVH outperforms 88.10% of its industry peers.
  • COVH has a Quick Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of COVH (1.16) is better than 88.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 242.64% over the past year.
  • COVH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.16% yearly.
  • Looking at the last year, COVH shows a decrease in Revenue. The Revenue has decreased by -5.26% in the last year.
  • COVH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.29% yearly.
EPS 1Y (TTM)242.64%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%

3.2 Future

  • Based on estimates for the next years, COVH will show a small growth in Earnings Per Share. The EPS will grow by 0.90% on average per year.
  • COVH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.55% yearly.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.10 indicates a rather expensive valuation of COVH.
  • The rest of the industry has a similar Price/Earnings ratio as COVH.
  • COVH's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.33.
  • A Price/Forward Earnings ratio of 13.69 indicates a correct valuation of COVH.
  • 64.29% of the companies in the same industry are cheaper than COVH, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 24.12. COVH is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.1
Fwd PE 13.69
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as COVH.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of COVH indicates a slightly more expensive valuation: COVH is more expensive than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.11
EV/EBITDA 17.16
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COVH does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.68
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.52%, COVH is a good candidate for dividend investing.
  • COVH's Dividend Yield is a higher than the industry average which is at 4.99.
  • Compared to an average S&P500 Dividend Yield of 1.91, COVH pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.52%

5.2 History

  • The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 19.17% of the earnings are spent on dividend by COVH. This is a low number and sustainable payout ratio.
DP19.17%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (1/14/2026, 7:00:00 PM)

23.6

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22
Earnings (Next)02-16
Inst Owners31.31%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.73B
Revenue(TTM)260.60M
Net Income(TTM)205.50M
Analysts82.86
Price Target18.67 (-20.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.52%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.1
Fwd PE 13.69
P/S 14.31
P/FCF 16.11
P/OCF 10.19
P/B 1.07
P/tB 1.18
EV/EBITDA 17.16
EPS(TTM)1.38
EY5.85%
EPS(NY)1.72
Fwd EY7.3%
FCF(TTM)1.46
FCFY6.21%
OCF(TTM)2.32
OCFY9.81%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)5.68
PEG (5Y)N/A
Graham Number26.22
Profitability
Industry RankSector Rank
ROA 2.88%
ROE 5.87%
ROCE 4.15%
ROIC 3.67%
ROICexc 4.06%
ROICexgc 4.3%
OM 101.41%
PM (TTM) 78.86%
GM N/A
FCFM 88.79%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexgc growth 3Y33.75%
ROICexgc growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Debt/EBITDA 6.96
Cap/Depr 151.01%
Cap/Sales 51.57%
Interest Coverage 4.11
Cash Conversion 103.55%
Profit Quality 112.6%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.04
F-Score5
WACC5.38%
ROIC/WACC0.68
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)242.64%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.66%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.4%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y24.44%
OCF growth 3Y30.01%
OCF growth 5Y4.76%

COVIVIO HOTELS SACA / COVH.PA FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 4 / 10 to COVH.PA.


What is the valuation status of COVIVIO HOTELS SACA (COVH.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Overvalued.


How profitable is COVIVIO HOTELS SACA (COVH.PA) stock?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for COVH stock?

The Price/Earnings (PE) ratio for COVIVIO HOTELS SACA (COVH.PA) is 17.1 and the Price/Book (PB) ratio is 1.07.


Can you provide the expected EPS growth for COVH stock?

The Earnings per Share (EPS) of COVIVIO HOTELS SACA (COVH.PA) is expected to grow by 3.01% in the next year.